ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹50,298 Cr | ₹34,858 Cr | ₹27,637 Cr | ₹24,494 Cr | ₹26,700 Cr |
What is the latest Total Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹50,298 Cr |
| Mar2025 | ₹34,858 Cr |
| Mar2024 | ₹27,637 Cr |
| Mar2023 | ₹24,494 Cr |
| Mar2022 | ₹26,700 Cr |
How is Total Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹50,298 Cr | 44.29 | |
| Mar2025 | ₹34,858 Cr | 26.13 | |
| Mar2024 | ₹27,637 Cr | 12.83 | |
| Mar2023 | ₹24,494 Cr | -8.26 | |
| Mar2022 | ₹26,700 Cr | - | |
Compare Total Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹111,081.6 Cr | -2.6% | 0.1% | 16.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | -2.6% |
0.1% |
16.6% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses